Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

SCOLR Pharma, Inc. (SCLR)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsSep-30-11Jun-30-11Mar-31-11Dec-31-10Sep-30-10Jun-30-10Mar-31-10Dec-31-09
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Net income  -0.8-0.5-1.1-4.5-1.0-0.5-0.8-1.6
Depreciation and amortization  0.10.10.10.20.10.10.10.1
Stock-based compensation  0.00.1 -0.20.10.1 -1.0
Change in working capital   [+]-0.1-0.60.0-0.1-0.2-0.30.00.1
Other operating activities  0.2-0.60.22.00.1-0.20.01.6
Cash from operations  -0.6-1.6-0.7-2.6-0.9-0.8-0.7-0.8
   
Capital expenditures   [+]0.00.00.00.00.00.00.0-0.1
Purchases of intangible assets  0.00.0  0.0-0.2  
Other cash from investing   0.4-0.20.10.10.2-0.20.1
Cash from investing  0.00.6-0.20.10.10.0-0.20.0
   
Issuance of common stock, net     -0.1 3.8  
Other cash from financing   1.2 -3.8 0.0  
Cash from financing  0.01.20.0-3.90.03.80.00.0
   
Free cash flow  -0.6-1.6-0.7-2.6-0.9-0.8-0.7-0.9
        Per share (diluted)  ($0.01)($0.03)($0.02)($0.06)($0.02)($0.02)($0.02)($0.02)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy